SOS Limited Unsponsored ADR (NYSE:SOS – Get Free Report) shares traded up 10.5% on Monday . The company traded as high as $1.1699 and last traded at $1.1050. Approximately 155,378 shares changed hands during trading, an increase of 576% from the average session volume of 22,997 shares. The stock had previously closed at $1.00.
Analyst Ratings Changes
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of SOS in a research note on Thursday, June 11th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, SOS currently has a consensus rating of “Sell”.
Get Our Latest Research Report on SOS
SOS Trading Up 10.5%
SOS (NYSE:SOS – Get Free Report) last announced its quarterly earnings results on Friday, May 15th. The company reported ($669.48) earnings per share for the quarter. The firm had revenue of $32.35 million for the quarter.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in SOS stock. Invesco Ltd. purchased a new position in SOS Limited Unsponsored ADR (NYSE:SOS – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 315,968 shares of the company’s stock, valued at approximately $439,000. Invesco Ltd. owned approximately 4.65% of SOS at the end of the most recent quarter. 1.92% of the stock is currently owned by institutional investors and hedge funds.
About SOS
SOS Limited is a China-based specialty chemical company that develops, manufactures and markets a broad portfolio of water treatment, glycol and surfactant products. Founded in 1997 and headquartered in Shanghai, the company focuses on delivering high-performance solutions for industrial, municipal and household applications. Its core mission is to address water conservation and pollution control challenges while supporting downstream industries with essential chemical inputs.
The company’s primary offerings include a range of water treatment chemicals such as coagulants, flocculants and scale inhibitors designed for use in power plants, petrochemical facilities, and municipal waterworks.
Recommended Stories
- Five stocks we like better than SOS
- Buy CrowdStrike Before the Stock Split? Here’s the Case
- Investors Are Buying Into Sweetgreen Again—Should They?
- Burlington Is Winning Over Shoppers But Investors Need Patience
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
Receive News & Ratings for SOS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SOS and related companies with MarketBeat.com's FREE daily email newsletter.
